EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube

CAR-T is a form of immunotherapy recently approved for the treatment of myeloma in the United States and Europe. While the process of manufacturing and administrating this treatment, as well as side effects can be challenging, results of clinical trials have been promising in myeloma.

This video explains how CAR-T cell therapy works.

 

 

If you are interested in CAR-T therapy, read the articles below: